María Cerrillo, M.D., Ph.D.

Reproductive Endocrinology and Infertility Specialist at IVI Madrid

IVI Madrid

Biography

Dr. Cerrillo is a full-time Reproductive Endocrinology and Infertility specialist at IVI Madrid. She obtained her Medical degree in Surgery and Medicine at the University of Miguel Hernandez de elche (Alicante) in 2001, completed her residency in Obstetrics and Gynaecology in General Hospital of Albacete between 2002-2006, and obtained her doctorate degree “cum laude” in 2010 in the Pediatrics, Obstetrics and Gynaecology Department of the University of Rey Juan Carlos I (URJC). In addition, she obtained a Master’s degree in Reproductive Medicine in 2011 of URJC.

As a researcher, her main focus is the study of the stimulation protocols and the ovarian hyperstimulation sydrome, implantation process, and poor reponders.
Dr Cerrillo has published over 10 original “peer review” articles in leading reproductive journals (Hum Reprod, Fertil & Steril, etc.) and wrote 15 book chapters on the reproductive medicine, ultrasound in infertility and guidelines or protocols in reproduction. She has also participated as an investigator in competitive projects and is member of IdiPAZ since 2017

Dr. Cerrillo has been involved in teaching in Medicine career since 2004 in Castilla la Mancha University, imparting seminars in Obstetrics and Gynecology. Presently, she lectures in obstetrics and gynacology in URJC since 2009, and as part of the Master’s Degree in Human Reproduction (Obstetrics and Gynaecology Department of University of Rey Juan Carlos) faculty. In addition, she participates in teaching of Expert nurse in medicine-reproduction course at URJC since 2007, and in a Master’s degree Program of European University since 2016.

Medicine in University of Miguel Hernandez de Elche, Alicante, Spain	1996-2001
Fellowship IVI Madrid, Madrid, Spain	2005
Ph.D (Medicine) University of Rey Juan Carlos, Spain	2010
Master Reproduction Medicine URJC	2011

Honors and recognition

Spanish Fertility Society Award	2007
Salud 2000 Foundation Award	2004
Spanish Fertility Society Award	2000

Publications

DuoStim cycles potentially boost reproductive outcomes in poor prognosis patients.
Cecchino GN Roque M Cerrillo M Filho RDR Chiamba FDS Hatty JH García-Velasco JA
Gynecol Endocrinol. 2020 Sep 21:1-4. doi: 10.1080/09513590.2020.1822804. Online ahead of print.

Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
Cerrillo M Herrero L Guillen A Mayoral M García-Velasco JA
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10297.

Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
Cerrillo M Herrero L Guillen A Mayoral M García-Velasco JA
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10297.

Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.
Puente J Fabris A Patel J Patel A Cerrillo M Requena A García-Velasco JA
Reprod Biol Endocrinol 2016; 14: 60

Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease
Puente J Fabris A Patel J Patel A Cerrillo M Requena A García-Velasco JA
Reprod Biol Endocrinol, 14(1):60, 2016

Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
Cerrillo M Herrero L Guillen A Mayoral M García-Velasco JA
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10297.

Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
Cerrillo M Herrero L Guillen A Mayoral M García-Velasco JA
Rambam Maimonides Med J. 2017 Apr 28;8(2). doi: 10.5041/RMMJ.10297.

Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.
Puente J Fabris A Patel J Patel A Cerrillo M Requena A García-Velasco JA
Reprod Biol Endocrinol 2016; 14: 60

Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease
Puente J Fabris A Patel J Patel A Cerrillo M Requena A García-Velasco JA
Reprod Biol Endocrinol, 14(1):60, 2016

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
Bermejo A Cerrillo M Ruiz-Alonso M Blesa D Simón C Pellicer A García-Velasco JA
Fertil Steril 101(1):138-146, 2014

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression
Bermejo A Cerrillo M Ruiz M Blesa D Simón C Pellicer A García-Velasco JA
Fertil Steril, 101:138-46, 2013.

Natural lh surge vs hCG triggered vs hormone replace treatment (HRT): do pregnancy rates differ?
Cerrillo M Guillen A Zapata A Herrero I Requena A García-Velasco JA
Fertil Steril, 100(3):S95-96, 2013.

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
Bermejo A Cerrillo M Ruiz-Alonso M Blesa D Simón C Pellicer A García-Velasco JA
Fertil Steril 101(1):138-146, 2014

Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
Cerrillo M Pacheco A Rodríguez S Gómez R Delgado F Pellicer A García-Velasco JA
Fertil Steril. 95:2517-9, 2011.

Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression
Bermejo A Cerrillo M Ruiz M Blesa D Simón C Pellicer A García-Velasco JA
Fertil Steril, 101:138-46, 2013.

Natural lh surge vs hCG triggered vs hormone replace treatment (HRT): do pregnancy rates differ?
Cerrillo M Guillen A Zapata A Herrero I Requena A García-Velasco JA
Fertil Steril, 100(3):S95-96, 2013.

Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new
García-Velasco JA Motta L López A Mayoral M Cerrillo M Pacheco A
Fertil Steril. 94:2820-3, 2010.

GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use.
Martínez-Salazar J Cerrillo M Quea G Pacheco A García-Velasco JA
Reprod Biomed Online. 19:156-61, 2009.

Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
Cerrillo M Rodríguez S Mayoral M Pacheco A Martínez-Salazar J García-Velasco JA
Fertil Steril. 91(4 Suppl):1526-8, 2009.

Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
Cerrillo M Pacheco A Rodríguez S Gómez R Delgado F Pellicer A García-Velasco JA
Fertil Steril. 95:2517-9, 2011.

Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new
García-Velasco JA Motta L López A Mayoral M Cerrillo M Pacheco A
Fertil Steril. 94:2820-3, 2010.

GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use.
Martínez-Salazar J Cerrillo M Quea G Pacheco A García-Velasco JA
Reprod Biomed Online. 19:156-61, 2009.

Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
Cerrillo M Rodríguez S Mayoral M Pacheco A Martínez-Salazar J García-Velasco JA
Fertil Steril. 91(4 Suppl):1526-8, 2009.

Cerrillo M Cecchino GN María Cruz Mayoral M Pacheco A Labarta E García-Velasco JA O-171 Comparison of day-5 serum progesterone levels using different routes of administration for artificial endometrial preparation: is there any significant intrapatient variation?. Presented at the 36th annual meeting of the European Society of Human Reproduction and Embryology, Copenhagen,Denmark, July 5-8, 2020

Cecchino G Cerrillo M Cruz M Garcia Velasco J Retrospective analysis of DuoStim cycles shows similar overall performance and oocyte quality between follicular and luteal phase stimulation. Presented at the 33rd annual meeting of the European Society of Human Reproduction and Embryology, Geneva,Switerland, July 1-4,2018

Cerrillo M Cruz M Ferrando R García Velasco JA Freeze-all strategy in endometriosis patients - a new indication?. , , July 2-5 ,2017

María Cerrillo, M.D., Ph.D.

Biography

Education and Training

Honors and recognition

Publications

Presentations